prescribe Dexcom G7: the most accurate CGM system1 for confident diabetes management

From the #1 recommended continuous glucose monitoring brand2,3

Dexcom G7 CGM

Smart device sold separately.* 

Meet Dexcom G7



The wait is over

Dexcom G7 now integrates with the Tandem t:slim X2™ insulin pump and Beta Bionics iLet Bionic Pancreas.

Learn More

Dexcom G7, Tandem, Beta Bionics

earl dexcom g7

Image shown does not include required overpatch. 

Please be sure to follow instructions for using the overpatch.




new! expanded Medicare coverage

Due to recent Medicare changes, millions more people are now covered for Dexcom CGM. Dexcom G7 is the most accurate CGM system1 covered by Medicare—and it’s easy to use and get started!4

No other CGM system is less expensive than Dexcom G7 for Medicare patients.

Learn More

the most accurate CGM system1

For reliable treatment decisions that lead to proven results5-9


Industry-leading MARD (in adults):

8.2% for Dexcom G79 vs. 8.9% for Freestyle Libre 310

MARD (mean absolute relative difference) is a statistical measure of CGM accuracy; the lower the number the better.   


Clinically proven to5-9,11:

  • Lower A1C  

  • Increase time in range  

  • Reduce hyper- and hypoglycemia  

  • Improve quality of life 

 Dexcom G7 Continuous Glucose Monitor for type-1 and type-2 diabetes patients

Smart device sold separately.* 

the simple CGM system

For effortless diabetes management that leads to better adherence§,1

2x faster


2x faster warmup than FreeStyle Libre4,10 for easy setup and a quick start for you and your patients*

all in one


Simple all-in-one wearable for easy application4



60% smaller|| for comfortable, discreet wear


the most covered CGM brand12

For affordable care without compromising quality for the broadest audience of people with diabetes   


One-third of patients with commercial insurance have a $0 copay¶,12

3x graphic

Dexcom has 3x more patients paying $0 compared to FreeStyle Libre.#,13

our CGM portfolio can help patients with all types of diabetes gain greater glucose control5-9

The Dexcom CGM Portfolio is an expanding line of CGM systems that support a broad range of people with diabetes. Now you can simply prescribe the powerful CGM system that works best for your patients’ individual needs.

Dexcom G7 Personal Continuous Glucose Monitoring CGM System

Dexcom G7

the most accurate CGM system1

An intuitive user experience with the advanced accuracy that only Dexcom offers

Dexcom G6 Personal Continuous Glucose Monitoring CGM System

Dexcom G6

the most connected CGM system1

Industry-leading connectivity with pumps and pens for powerful integrated diabetes control


Dexcom G6 integrates with 60+ connected partners for seamless diabetes management  

As the first Class II integrated CGM (iCGM) system authorized by the FDA, Dexcom works with a range of connected insulin pens and automated insulin delivery (AID) system partners. We continue to pursue collaboration opportunities with product and digital health brands, offering a multifaceted approach to effective diabetes management for patients, caregivers, and healthcare providers.


See More on Device Integration

*For Medicare coverage of Continuous Glucose Monitoring (CGM), CMS requires use of a receiver. A patient may use a compatible smart device in conjunction with a receiver. †Medicare covers Dexcom CGM for patients who meet the Medicare coverage criteria. For a list of Medicare coverage criteria, please visit the Center for Medicare and Medicaid services website. ‡Under Medicare’s DME fee schedule, reimbursement and coinsurance for CGMs using CPT codes A4239 and E2103 are the same, regardless of CGM brand. §Based on use out of 30 days. ||Compared to a prior generation Dexcom CGM System. ¶Refers to estimated out-of-pocket cost for eligible commercially insured patients from the Dexcom CGM System sensor when claims are adjudicated as a pharmacy benefit, and includes benefits and offerings through available Dexcom programs, such as the voucher program. Actual cost may vary and is subject to individual insurance coverage. #For those with commercial pharmacy coverage. Individual costs may vary and is subject to individual insurance coverage.

1 Dexcom, data on file, 2022. 2 dQ&A US Diabetes Connections Patient Panel Report, Q3 2022 3 Seagrove HCP Survey Q2 2022. 4 Dexcom G7 CGM System User Guide. 5 Beck RW, et al. JAMA. 2017;317(4):371-378. 6 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374. 7 Martens T, et al. JAMA. 2021;325(22):2262-2272. 8 Laffel LM, et al. JAMA. 2020;323(23):2388-2396. 9 Welsh JB, et al. J Diabetes Sci Technol. 2022:19322968221099879. 10 FreeStyle Libre 3 Quick Start Guide. Abbott Diabetes Care Inc.; 2022. 11 Gilbert TR, et al. Diabetes Technol Ther. 2021;23(S1):S35-S39. 12 Managed Markets Insights & Technology, LLC. MMIT Analytics, June 2022. 13 IQVIA February 2022.

Contact Us

If you are a healthcare provider and want to learn more about Dexcom, please fill out the form and a representative will contact you. If you are a Dexcom User or Patient, please contact Dexcom here.

Contact Reason

Please note: To ensure a successful transaction, please provide information that matches the Provider’s medical license information.

Dexcom G7 samples are the only version currently available online.

Do not include prefix (Mr., Mrs., Dr.)
As listed on Provider’s medical license (no MD, Jr., Sr.)
Please use the Provider's NPI
Is your patient on a connected pump device?


By choosing to request info, you are granting Dexcom, Inc. permission to process your personal information to send you additional information and promotional communications related to Dexcom products. You may opt-out of these communications at any time. Dexcom respects the privacy and confidentiality of your personal information. The information you provide will be sent securely and subject to the Dexcom Terms of Use and Privacy Policy.